MRI与靶向活检预测根治性前列腺切除术后转移复发:肿瘤带起源的长期洞察
本研究纳入2009至2018年间接受根治性前列腺切除术的646例患者,中位随访8.3年,评估MRI与靶向活检数据对长期肿瘤学结局的预测价值。主要终点为转移复发,次要终点为生化复发(BCR)。MRI与活检衍生的Gleason模式4/5(GP4/5)负荷可强预测转移复发(c-index 0.82)和BCR(c-index 0.73)。外周带肿瘤结局较移行带/前纤维肌基质差,但多变量调整后带起源非独立预测因子。
要点
- MRI与靶向活检衍生的GP4/5负荷可强预测RP后转移复发和BCR。
- 10年转移复发率为11%,其中远处转移7.3%,BCR为28%。
- 外周带肿瘤BCR率高于移行带(32% vs 14%),但带起源非独立预测因子。
核心结论
- MRI与靶向活检衍生的GP4/5负荷对RP后转移复发具有强预测价值(c-index 0.82),并获得长期验证。
- 外周带肿瘤结局较差,但多变量调整后带起源非独立预测因子,可能由更高的GP4/5负荷介导。
研究设计与样本
- 回顾性队列研究,纳入2009至2018年间接受根治性前列腺切除术的646例患者,存活者中位随访8.3年。
- 术前变量包括MRI衍生的肿瘤体积和Gleason模式4/5(GP4/5)定量,肿瘤按带起源分为外周带(PZ)和移行带/前纤维肌基质(TZ/AFMS)。
主要发现
- 10年转移复发率为11%(95%CI=9-15),其中远处转移为7.3%(95%CI=5.1-10)。
- 10年生化复发(BCR)率为28%(95%CI=24-32)。
- MRI与活检衍生的GP4/5负荷预测转移复发的c-index为0.82(95%CI=0.76-0.88),预测BCR的c-index为0.73(95%CI=0.69-0.78)。
- 外周带肿瘤较TZ肿瘤10年BCR率更高(32% vs 14%,p=0.004),转移复发率数值更高(8.2% vs 3.7%),但置信区间重叠。
临床怎么用
- 可利用MRI与靶向活检对GP4/5负荷的定量来评估RP后转移复发风险,辅助长期随访策略制定。
- 对外周带肿瘤患者应关注更高的BCR风险,但带起源本身在多变量调整后不独立预测结局。
局限性
- 带起源与结局的关联在多变量调整后不显著,可能受GP4/5负荷介导,需进一步验证。
- 外周带与TZ肿瘤转移复发率的置信区间重叠,差异未达统计学显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prostate cancer recurrence after radical prostatectomy (RP) is primarily driven by tumor aggressiveness, but accurate long-term prediction remains challenging. We evaluated long-term oncological outcomes using magnetic resonance imaging (MRI) and targeted biopsy data in 646 patients treated with RP between 2009 and 2018, and the median follow-up for survivors was 8.3 yr. The primary end point was metastatic recurrence and the secondary end point was biochemical recurrence (BCR). Preoperative variables included MRI-derived tumor volume and quantification of Gleason pattern 4/5 (GP4/5). Tumors were classified according to zonal origin as peripheral zone (PZ) or transition zone/anterior fibromuscular stroma (TZ/AFMS). At 10 yr, metastatic recurrence occurred in 11% (95% confidence interval [CI] = 9-15), including distant metastases in 7.3% (95% CI = 5.1-10). BCR occurred in 28% (95% CI = 24-32). MRI- and biopsy-derived GP4/5 burden strongly predicted metastatic recurrence (c-index 0.82, 95% CI = 0.76-0.88) and BCR (c-index 0.73, 95% CI = 0.69-0.78). Outcomes were consistently worse for PZ compared with TZ tumors, with higher 10-yr BCR rates (32% vs 14%, p = 0.004) and numerically higher metastatic recurrence (8.2% vs 3.7%), with overlapping CIs. These findings provide long-term validation of MRI-based quantification of tumor aggressiveness to predict metastatic recurrence after RP. Although PZ tumors showed consistently worse outcomes in unadjusted analyses, zonal origin was not an independent predictor after multivariable adjustment, suggesting mediation through higher GP4/5 burden.
引用
- Delobel L, Villers A, Seguier D, et al. Long-term Prediction of Metastatic Recurrence in Patients Candidate to Radical Prostatectomy Using MRI and Targeted Biopsy: Insights into Tumor Zonal Origin. Eur Urol Oncol. 2026. PMID: 42686466. doi:10.1016/j.euo.2026.08.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。